Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness, or known active or chronic hepatitis B or C infection
Known human immunodeficiency virus (HIV) positivity or acquired immunodeficiency syndrome (AIDS)-related illness
Active or known history (standard pre-ASCT assessments) of:\r\n* Hepatitis B or C infection\r\n* Human immunodeficiency virus (HIV)\r\n* Acquired immunodeficiency syndrome (AIDS)
Known history of human immunodeficiency virus (HIV) or acquired immunodeficiency-related (AIDS) illnesses.
Known human immunodeficiency virus or acquired immunodeficiency syndrome related illness.
Known positive test for hepatitis B, hepatitis C, human immunodeficiency virus (HIV), or acquired immunodeficiency syndrome (AIDS)
Individuals who are known to have acquired immunodeficiency syndrome (AIDS) (cluster of differentiation [CD] 4 < 200 or an AIDS-defining illness) or are known to be human immunodeficiency virus (HIV) positive and not on highly active antiretroviral therapy (HAART) are ineligible
HIV uninfected and infected women (without acquired immunodeficiency syndrome [AIDS] defining illness)
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness that is not well controlled.
Known history of human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS)
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness (HIV-positive subjects on combination anti-retroviral therapy are ineligible
Acquired immune defects such as human immunodeficiency virus (HIV) or innate immunodeficiency
Active and clinically significant bacterial, fungal or viral infection including hepatitis B (HBV), hepatitis C (HCV), known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness (human immunodeficiency virus [HIV] testing is not required), including patients who have an active infection requiring systemic therapy
Known history of human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS)
Known uncontrolled human immunodeficiency virus (HIV) infection or known acquired immunodeficiency syndrome (AIDS); patients with documented controlled HIV infection (CD4 > 200 and undetectable viral load) will be included
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness, or hepatitis B or C
Human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS)-related illness
Active and clinically significant bacterial, fungal or viral infection including hepatitis B (HBV), hepatitis C (HCV), known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness (HIV testing is not required)
Human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness
Known HIV or acquired immunodeficiency syndrome-related illness, acute or history of chronic hepatitis B or C.
Known significant immunodeficiency due to underlying illness (e.g. HIV/acquired immunodeficiency syndrome [AIDS]) and/or immune-suppressive medication including high-dose corticosteroids (defined as >= 20 mg/day prednisone or equivalent which is ongoing at the time of enrollment and/or was taken for more than 4 weeks within the preceding 2 months of enrollment)
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness.
Current active infections with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), hepatitis B, and hepatitis C requiring treatment
Active bacterial, fungal or viral infection including hepatitis B (HBV), hepatitis C (HCV), known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) -related illness
Has a diagnosis of immunodeficiency, including human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)
Known active human immunodeficiency virus (HIV), acquired immunodeficiency syndrome (AIDS) related illness, or hepatitis B or C infection
Known severe congenital or acquired cellular or humoral immunodeficiency such as common variable immunodeficiency.
Active uncontrolled infection, including known history of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) or hepatitis B or C
Known history of human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS)-related disease
Human immunodeficiency virus (HIV) virus infection irrespective of viral load, treatment status, or cluster of differentiation 4 (CD4) count, or acquired immunodeficiency syndrome (AIDS)-related illness; HIV testing is not required by this protocol
The subject has a history of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), chronic hepatitis B or hepatitis C or is otherwise reasonably suspected to meet criteria for the diagnosis of a known congenital or acquired disorder causing systemic immunosuppression
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness; (testing is not required for eligibility)
Significant immunodeficiency making the patient unlikely to benefit from pembrolizumab therapy including a diagnosis of acquired immunodeficiency syndrome (AIDS), active hepatitis B or hepatitis C, or organ transplant requiring immunosuppressive therapy
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome-related disease
Other clinically significant disorders such as:\r\n* Known active infection requiring systemic treatment, infection with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness, chronic hepatitis B or known or suspected active hepatitis C infection\r\n* Serious non-healing wound or ulcer\r\n* Malabsorption syndrome\r\n* Symptomatic hypothyroidism\r\n* Moderate to severe hepatic impairment (Child-Pugh B or C)\r\n* Requirement for hemodialysis or peritoneal dialysis\r\n* History of solid organ transplantation
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness
Patients with known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness
Known human immunodeficiency virus- or acquired immunodeficiency syndrome-related illness.
Known human immunodeficiency virus (HIV) infection requiring antiretroviral medications and those with acquired immunodeficiency syndrome (AIDS)
Patients with known human immunodeficiency virus (HIV) positivity or acquired immunodeficiency syndrome (AIDS)-related illness are not eligible
Known history of human immunodeficiency virus (HIV) or acquired immunodeficiency-related (AIDS) illnesses.
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness, active or symptomatic viral hepatitis or chronic liver disease
The subject has a history of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), chronic hepatitis B or hepatitis C or is otherwise reasonably suspected to meet criteria for the diagnosis of a known congenital or acquired disorder causing systemic immunosuppression
Patients with a known human immunodeficiency virus infection (HIV 1/2 antibodies) or acquired immunodeficiency syndrome (HIV/AIDS)
Active and clinically significant bacterial, fungal, or viral infection including hepatitis B (HBV), hepatitis C (HCV), known human immunodeficiency virus (HIV), or acquired immunodeficiency syndrome (AIDS) related illness.
Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome((HIV/AIDS)
Have human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome-related illness.
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness or other active infection; patients with HIV but no evidence of AIDS will be considered candidates
Known human immunodeficiency virus (HIV) positivity or autoimmune deficiency syndrome (AIDS)-related illness
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness
If there is clinical suspicion of acquired immunodeficiency syndrome (AIDS), a human immunodeficiency virus (HIV) test is recommended within 42 days prior to registration; Note: HIV positive patients without AIDS are eligible for enrollment on this study
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness
Known human immunodeficiency virus infection or acquired immunodeficiency syndrome-related illness.
Subject has a known active hepatitis B or C infection, Human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS)
Participant has known human immunodeficiency virus infection or acquired immunodeficiency syndrome-related illness
History of human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS)-related illness
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness
Has human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS)-related illness, or a history of immunodeficiency
Known human immunodeficiency virus (HIV) positivity or acquired immunodeficiency syndrome (AIDS) related illness or other serious medical illness
Has a known human immunodeficiency virus infection (HIV 1/2 antibodies) or acquired immunodeficiency syndrome (HIV/AIDS)
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness
Known human immunodeficiency virus positivity or acquired immunodeficiency syndrome related illness or other serious medical condition
Patients with acquired immunodeficiency syndrome (AIDS-related illnesses) or known human immunodeficiency virus (HIV) disease must: Have a CD4 count greater than or equal to 200 cells/uL within 30 days prior to beginning study therapy; Be off all antiretroviral therapy (prophylaxis/treatment) greater than 60 days prior to beginning study therapy; Have no evidence of opportunistic infections.
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness or other active infection
E 12. Acquired immunodeficiency syndrome (AIDS-related illnesses) or known HIV disease requiring antiretroviral treatment.
Active and clinically significant bacterial, fungal or viral infection including hepatitis B (HBV), hepatitis C (HCV), known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness.
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness
Known human immunodeficiency virus (HIV) positivity or acquired immune deficiency syndrome (AIDS)-related illness, active hepatitis B virus, or active hepatitis C virus
Evidence of ongoing systemic bacterial, fungal, or viral infection. Known human immunodeficiency virus (HIV) infection or acquired-immunodeficiency syndrome (AIDS)-related illness
Acquired immunodeficiency syndrome (AIDS)-related illnesses or known Human immunodeficiency virus (HIV) disease requiring antiretroviral treatment.
Acquired immuno deficiency syndrome (AIDS-related illnesses) or known human immunodeficiency virus (HIV) disease requiring antiretroviral treatment
Known human immunodeficiency virus-positive serology, acquired immunodeficiency syndrome (AIDS), or an AIDS-related illness.
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness, which may compromise the efficacy of immunostimulatory therapy
Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)
Human immunodeficiency virus infection or acquired immunodeficiency syndrome-related illness.
Known seropositivity for human immunodeficiency virus (HIV) or diagnosis of acquired immunodeficiency syndrome (AIDS), positive for hepatitis B surface antigen, or seropositive for hepatitis C virus
Human immunodeficiency virus or acquired immunodeficiency syndrome
Coexisting cancer in other organs or acquired immunodeficiency syndrome/human immunodeficiency virus (AIDS/HIV)
Has been diagnosis of active acquired immunodeficiency syndrome (AIDS) or hepatitis B/C and other significant disease or disorders
Active and clinically significant bacterial, fungal, or viral infection including hepatitis B (HBV), hepatitis C (HCV), known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness
Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) related illness